Delayed Onset Malignant Hyperthermia after Sevoflurane | Zendy

Turhan Kahraman | Zendy; Volkan Baytaş | Zendy; Yeşim Batislam | Zendy; Oya Özatamer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Delayed Onset Malignant Hyperthermia after Sevoflurane

Author(s) -

Turhan Kahraman,

Volkan Baytaş,

Yeşim Batislam,

Oya Özatamer

Publication year - 2013

Publication title -

case reports in anesthesiology

Language(s) - English

Resource type - Journals

eISSN - 2090-6390

pISSN - 2090-6382

DOI - 10.1155/2013/712710

Subject(s) - malignant hyperthermia , tachypnea , medicine , sevoflurane , desflurane , rhabdomyolysis , anesthesia , hyperthermia , acidosis , muscle rigidity , halothane , inhalation , tachycardia

Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research